ACH vs RARE · rev $1.24B vs rev $350.0M
Accendra Health Inc (ACH) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
Accendra Health Inc (ACH) is a medical distribution company listed on NYSE.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported ACH revenue for 2026-06-30 was $1.24B. Net income was -$95.5M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. ACH currently screens at market cap $237.8M.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
ACH currently screens at market cap $237.8M. RARE currently screens at market cap $2.79B.
Not investment advice. Open the ACH and RARE stock pages for the full models.
Not investment advice.